Neurocrine Biosciences Inc Note 2.250 5/1 shares owned by Royal Bank of Canada
Quarter-by-quarter ownership of Neurocrine Biosciences Inc Note 2.250 5/1 shares owned by Royal Bank of Canada
from 13F filings
Historical chart of Royal Bank of Canada investment in Neurocrine Biosciences Inc Note 2.250 5/1
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences Inc Note 2.250 5/1 held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences Inc Note 2.250 5/1 by Royal Bank of Canada
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $177k | 106k | 1.67 |
| 2023-09-30 | $159k | 106k | 1.50 |
| 2023-06-30 | $141k | 106k | 1.33 |
| 2022-12-31 | $9.0k | 6.0k | 1.50 |
| 2022-09-30 | $9.3k | 7.0k | 1.33 |
| 2021-06-30 | $5.0k | 4.0k | 1.25 |
| 2021-03-31 | $5.0k | 4.0k | 1.25 |
| 2020-12-31 | $6.0k | 4.0k | 1.50 |
| 2020-09-30 | $6.0k | 4.0k | 1.50 |
| 2020-06-30 | $7.0k | 4.0k | 1.75 |
| 2020-03-31 | $5.0k | 4.0k | 1.25 |
| 2019-12-31 | $6.0k | 4.0k | 1.50 |
Top funds holding Neurocrine Biosciences Inc Note 2.250 5/1
View all funds holding Neurocrine Biosciences Inc Note 2.250 5/1